catechin has been researched along with dinoprostone in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (9.62) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 20 (38.46) | 29.6817 |
2010's | 25 (48.08) | 24.3611 |
2020's | 2 (3.85) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Berg, PA; Daniel, PT; Holzschuh, J | 1 |
Berg, PA; Daniel, PT; Diao, GJ; Holzschuh, J | 1 |
Ito, K; Nishimura, N; Tajima, S | 1 |
Berg, AU; Berg, PA; Daniel, PT; Falcioni, F | 1 |
Delaissé, JM; Eeckhout, Y; Vaes, G | 1 |
Choi, YJ; Kwon, TK; Park, JW; Suh, SI | 1 |
August, DA; Ho, CT; Hong, J; Smith, TJ; Yang, CS | 1 |
Ahmed, S; Goldberg, VM; Haqqi, TM; Hasnain, A; Lalonde, M; Rahman, A | 1 |
Imamura, M; Itami, A; Kaganoi, J; Kawabe, A; Komoto, I; Li, ZG; Maeda, M; Sato, F; Shimada, Y | 1 |
Hagihara, K; Koshimizu, K; Murakami, A; Ohigashi, H; Takahashi, D | 1 |
Lee, IS; Lee, SJ; Mar, W | 1 |
Cui, Y; Kim, DS; Kim, SK; Kwon, SB; Park, KC; Park, SH; Yoon, JA | 1 |
Ahn, BH; Joe, EH; Kim, SY; Lee, YH; Min, DS; Min, KJ | 1 |
Adhami, VM; Gupta, S; Hussain, T; Mukhtar, H | 1 |
Drewe, J; Porath, D; Riegger, C; Schwager, J | 1 |
Bose, M; Carothers, AM; Hong, J; Hou, Z; Ju, J; Liao, J; Lin, Y; Liu, YY; Ma, J; Pan, Z; Shih, WJ; Yang, CS; Yang, GY; Zhou, JN | 1 |
Dushenkov, S; Ghai, G; Ho, CT; Huang, MT; Liu, Y; Lo, CY; Ramji, D | 1 |
Deguchi, A; Joe, AK; Mckoy, JF; Moriwaki, H; Shimizu, M; Weinstein, IB | 1 |
Albini, A; Bagnato, A; Decandia, S; Di Castro, V; Elia, G; Natali, PG; Rosanò, L; Spinella, F | 1 |
An, NH; Hong, SH; Jeong, HJ; Kim, HM; Kim, SJ; Lee, HJ; Lee, KM; Myung, NY; Park, SK; Um, JY; Yang, WM | 1 |
Burnett, BP; Jia, Q; Levy, RM; Zhao, Y | 1 |
Bauer, J; Hoffmann, M; Koeberle, A; Northoff, H; Verhoff, M; Werz, O | 1 |
Altavilla, D; Bitto, A; Burnett, BP; Di Stefano, V; Minutoli, L; Polito, F; Squadrito, F | 1 |
Ha, J; Hwang, JT; Kwon, DY; Lee, YK; Park, IJ; Park, OJ | 1 |
Au, AY; Frondoza, CG; Grzanna, MW; Heinecke, LF; Mochal, CA; Rashmir-Raven, A | 1 |
Banerjee, S; Bhattacharyya, S; Chakraborty, J; Chattopadhyay, S; Das, K; Das, T; Mohanty, S; Sa, G; Saha, B; Sakib Hossain, DM | 1 |
Choi, SE; Kim, JH; Kwon, JH; Lee, MW; Park, KH | 1 |
Choi, SE; Han, BH; Jeong, MS; Joo, SS; Lee, DI; Lee, MW; Park, KH; Seo, SJ | 1 |
Meydani, M; Meydani, SN; Pae, M; Ren, Z; Shang, F; Smith, D; Wu, D | 1 |
Ardèvol, A; Blay, M; González-Abuín, N; Martinez-Micaelo, N; Pinent, M; Richart, C; Terra, X | 1 |
Katiyar, SK; Singh, T | 1 |
Ferrario, A; Gomer, CJ; Luna, M; Rucker, N; Wong, S | 1 |
Altavilla, D; Bitto, A; David, A; Irrera, N; Minutoli, L; Rinaldi, M; Squadrito, F; Venuti, FS | 1 |
Chang, JZ; Chen, HM; Deng, YT; Kuo, MY; Yang, WH | 1 |
Altavilla, D; Arena, S; Bitto, A; Burnett, BP; Irrera, N; Magno, C; Minutoli, L; Polito, F; Rinaldi, M; Squadrito, F | 1 |
Chang, Y; He, YF; Hu, SS; Jin, J; Wang, D; Wei, W; Wu, YJ | 1 |
Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z | 1 |
Byun, EB; Byun, EH; Byun, MW; Kim, JH; Kim, JK; Lee, JW; Park, JH; Park, SH; Song, BS; Song, DS; Sung, NY | 1 |
Bennett, S; Clarke, KA; Darby, G; Dew, TP; Farrar, MD; Massey, KA; Nicolaou, A; Rhodes, LE; Watson, RE; Williamson, G | 1 |
Lee, JB; Min, YK; Shin, YO; Song, YJ; Yang, HM | 1 |
Delvin, E; Denis, MC; Desjardins, Y; Dudonné, S; Furtos, A; Garofalo, C; Levy, E; Marcil, V; Marette, A; Montoudis, A | 1 |
Aggarwal, V; Monga, J; Nongalleima, K; Sharma, M; Suthar, SK | 1 |
Adamo, EB; Altavilla, D; Bitto, A; Calò, M; Galfo, F; Interdonato, M; Irrera, N; Marini, H; Minutoli, L; Pallio, G; Pizzino, G; Rinaldi, M; Squadrito, F; Trichilo, V | 1 |
Clarke, KA; Dew, TP; Farrar, MD; Mason, S; Massey, KA; Nicolaou, A; Rhodes, LE; Watson, RE; Williamson, G | 1 |
Altavilla, D; Arcoraci, V; Bitto, A; Galfo, F; Irrera, N; Macrì, A; Minutoli, L; Pallio, G; Pizzino, G; Squadrito, F; Squadrito, G | 1 |
Abadie, J; Beck, L; Gauthier, O; Guicheux, J; Hivernaud, V; Houard, X; Krisa, S; Lesoeur, J; Masson, M; Merceron, C; Mével, E; Nourissat, G; Richard, T; Urban, N; Vinatier, C; Wittrant, Y | 1 |
Altavilla, D; Bitto, A; Canalini, F; Giuliani, D; Guarini, S; Irrera, N; Minutoli, L; Ottani, A; Pallio, G; Rinaldi, M; Squadrito, F; Vandini, E; Zaffe, D | 1 |
Jin, J; Sun, H; Wang, M; Yang, H; Zhu, S | 1 |
Dong, B; Feng, J; Gao, H; Han, S; Li, JX; Li, XX; Tang, M; Wang, QQ; Yang, S; Yuan, R; Zhao, LC | 1 |
Jiang, M; Jiao, JY; Li, Y; Lian, LH; Lin, YC; Liu, J; Nan, JX; Piao, MH; Qiao, CY; Shang, Y; Sun, RH; Wu, YL; Ye, H; Zhan, ZY; Zhang, ZH | 1 |
3 trial(s) available for catechin and dinoprostone
Article | Year |
---|---|
Oral green tea catechin metabolites are incorporated into human skin and protect against UV radiation-induced cutaneous inflammation in association with reduced production of pro-inflammatory eicosanoid 12-hydroxyeicosatetraenoic acid.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Administration, Oral; Adult; Camellia sinensis; Catechin; Dinoprostone; Dose-Response Relationship, Radiation; Erythema; Female; Humans; Male; Middle Aged; Skin; Ultraviolet Rays | 2013 |
Oligonol supplementation attenuates body temperature and the circulating levels of prostaglandin E2 and cyclooxygenase-2 after heat stress in humans.
Topics: Adult; Body Temperature; Catechin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dietary Supplements; Dinoprostone; Hot Temperature; Humans; Immersion; Litchi; Male; Phenols; Plant Extracts; Reference Values; Skin Temperature; Stress, Physiological; Water; Young Adult | 2013 |
A randomized controlled trial of green tea catechins in protection against ultraviolet radiation-induced cutaneous inflammation.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Catechin; Dietary Supplements; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Erythema; Female; Humans; Inflammation; Male; Middle Aged; Skin; Sunburn; Tea; Ultraviolet Rays; Young Adult | 2015 |
49 other study(ies) available for catechin and dinoprostone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
The pathogenesis of cianidanol-induced fever.
Topics: Catechin; Cyclic AMP; Cyclic GMP; Dinoprostone; Fever; Humans; Indomethacin; Interleukin-1; Macrophages; Mitogens; Phospholipases A; Phospholipases A2; Phytohemagglutinins; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Radioimmunoassay | 1988 |
Interference of the flavonoid compound cianidanol with macrophage function and lymphocyte activating mechanisms.
Topics: Calcium; Catechin; Cyclic AMP; Cyclic GMP; Dinoprostone; Humans; In Vitro Techniques; Lymphocyte Activation; Macrophages; Phospholipases A | 1988 |
Suppression of delayed-type hypersensitivity mediated by macrophage-like cells in mice with experimental liver injury.
Topics: 1-Naphthylisothiocyanate; Animals; Carbon Tetrachloride; Catechin; Chemical and Drug Induced Liver Injury; Dinoprostone; Drug Hypersensitivity; Hypersensitivity, Delayed; Indomethacin; Liver Diseases; Macrophages; Male; Mice; Mice, Inbred BALB C; Picryl Chloride; Prostaglandins E; Spleen; Superoxides; T-Lymphocytes, Regulatory | 1985 |
Influence of cianidanol on specific and non-specific immune mechanisms.
Topics: B-Lymphocytes; Benzopyrans; Catechin; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Immunity; Immunoglobulins; In Vitro Techniques; Indomethacin; Lymphocyte Activation; Macrophages; Mitogens; Phagocytosis; Prostaglandins E | 1986 |
Inhibition of bone resorption in culture by (+)-catechin.
Topics: Animals; Benzopyrans; Bone Resorption; Calcium; Catechin; Dinoprostone; Isoenzymes; L-Lactate Dehydrogenase; Mice; Organ Culture Techniques; Parathyroid Hormone; Prostaglandins E; Tretinoin | 1986 |
Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cells.
Topics: Animals; Catechin; Cell Line; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Flavonoids; Isoenzymes; Macrophages; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Protein Tyrosine Phosphatases; RNA, Messenger; Signal Transduction; Up-Regulation; Vanadates | 2001 |
Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues.
Topics: Antioxidants; Arachidonic Acid; Biflavonoids; Catechin; Colonic Neoplasms; Dinoprostone; Enzyme Inhibitors; Flavonoids; Humans; Intestinal Mucosa; Lipoxygenase; Microsomes; Phenols; Polymers; Prostaglandin-Endoperoxide Synthases; Tea; Tumor Cells, Cultured | 2001 |
Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes.
Topics: Antioxidants; Catechin; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Depression, Chemical; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Interleukin-1; Isoenzymes; L-Lactate Dehydrogenase; Membrane Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Reactive Oxygen Species; Tea | 2002 |
Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats.
Topics: Animals; Anticarcinogenic Agents; Catechin; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Dimethylnitrosamine; Dinoprostone; Disease Models, Animal; DNA Primers; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Esophagus; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator | 2002 |
Combinatorial effects of nonsteroidal anti-inflammatory drugs and food constituents on production of prostaglandin E2 and tumor necrosis factor-alpha in RAW264.7 murine macrophages.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Catechin; Cell Line; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Food Analysis; Food-Drug Interactions; Genistein; Indicators and Reagents; Indomethacin; Interferon-gamma; Isothiocyanates; Lipopolysaccharides; Macrophages; Mice; Protein Biosynthesis; Spectrophotometry, Infrared; Sulfonamides; Tumor Necrosis Factor-alpha | 2003 |
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose in murine macrophage cells.
Topics: Acetophenones; Animals; Catechin; Cell Line; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Gallic Acid; Humans; Hydrolyzable Tannins; Isoenzymes; Leukemia, Erythroblastic, Acute; Lipopolysaccharides; Macrophages; Medicine, Chinese Traditional; Membrane Proteins; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Paeonia; Plant Extracts; Plant Roots; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Structure-Activity Relationship; Tannins | 2003 |
Involvement of ERK AND p38 MAP kinase in AAPH-induced COX-2 expression in HaCaT cells.
Topics: Amidines; Catechin; Chromans; Cyclooxygenase 2; Dinoprostone; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Free Radical Scavengers; Humans; Imidazoles; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Keratinocytes; MAP Kinase Kinase 4; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyridines | 2004 |
Phospholipase D isozymes mediate epigallocatechin gallate-induced cyclooxygenase-2 expression in astrocyte cells.
Topics: 1-Butanol; Animals; Astrocytes; Astrocytoma; Blotting, Western; Carbazoles; Catechin; Cell Line, Tumor; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Indoles; Isoenzymes; Membrane Proteins; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphatidic Acids; Phospholipase D; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Isoforms; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection | 2004 |
Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acid; Catechin; Cell Division; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Humans; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2005 |
Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines.
Topics: Antioxidants; Catechin; Cell Line, Tumor; Cell Survival; Chemokines; Colon; Colonic Neoplasms; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; HT29 Cells; Humans; Interleukin-8; Kinetics; Macrophage Inflammatory Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; Up-Regulation | 2005 |
Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea.
Topics: Animals; Anticarcinogenic Agents; beta Catenin; Cadherins; Caffeine; Catechin; Dinoprostone; Extracellular Signal-Regulated MAP Kinases; Female; Genes, APC; HT29 Cells; Humans; Intestinal Neoplasms; Intestine, Small; Leukotriene B4; Male; Mice; Mice, Inbred C57BL; Phospholipases A; Phosphorylation; Proto-Oncogene Proteins c-akt | 2005 |
Inhibitory effects of black tea theaflavin derivatives on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and arachidonic acid metabolism in mouse ears.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Biflavonoids; Catechin; Dinoprostone; Drug Synergism; Ear; Edema; Female; Gallic Acid; Inflammation; Interleukin-1; Interleukin-6; Leukotriene B4; Lipoxygenase; Mice; Prostaglandin-Endoperoxide Synthases; Sulindac; Tea; Tetradecanoylphorbol Acetate | 2006 |
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
Topics: bcl-X Protein; Biotransformation; Blotting, Western; Catechin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; DNA Fragmentation; Enzyme Induction; ErbB Receptors; Genes, erbB-2; Genes, Reporter; Humans; Immunoprecipitation; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Transcription Factor AP-1 | 2005 |
Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.
Topics: Antineoplastic Agents; Catechin; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dinoprostone; Endothelin A Receptor Antagonists; Endothelin-1; Female; Humans; Ovarian Neoplasms; Promoter Regions, Genetic; RNA, Messenger; Tea | 2006 |
Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells.
Topics: Amyloid beta-Peptides; Anti-Inflammatory Agents; Astrocytoma; Catechin; Cyclooxygenase 2; Dinoprostone; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; JNK Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2007 |
A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation.
Topics: Acacia; Animals; Anti-Inflammatory Agents; Catechin; Cell Line, Transformed; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Flavonoids; HT29 Cells; Humans; Inflammation; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred ICR; Monocytes; Osteosarcoma; Plant Extracts; Scutellaria baicalensis; Sheep | 2007 |
Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1.
Topics: Anticarcinogenic Agents; Camellia sinensis; Catechin; Dinoprostone; Enzyme Inhibitors; Humans; Intramolecular Oxidoreductases; Microsomes; Prostaglandin H2; Prostaglandin-E Synthases | 2009 |
Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages.
Topics: Animals; Catechin; Cell Survival; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Flavonoids; I-kappa B Proteins; Lipopolysaccharides; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Male; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2009 |
Green tea catechin controls apoptosis in colon cancer cells by attenuation of H2O2-stimulated COX-2 expression via the AMPK signaling pathway at low-dose H2O2.
Topics: Acetylcysteine; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Blotting, Western; Catechin; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Free Radical Scavengers; HT29 Cells; Humans; Hydrogen Peroxide; Oxidants; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Ribonucleotides; Signal Transduction; Tea; Tumor Suppressor Protein p53 | 2009 |
Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate.
Topics: Aggrecans; Animals; Antioxidants; Cartilage, Articular; Catechin; Chondrocytes; Collagen Type II; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Gene Expression; Glycine max; Horses; Interleukin-1beta; NF-kappa B; Persea; Phenotype; Plant Extracts; Polymerase Chain Reaction; RNA; Tumor Necrosis Factor-alpha | 2010 |
Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins.
Topics: Adult; Apoptosis; Biflavonoids; Catechin; CD4-Positive T-Lymphocytes; Cell Survival; Dinoprostone; Gene Expression Regulation; Humans; Immune System; Interleukin Receptor Common gamma Subunit; Jurkat Cells; Lymphocyte Activation; Neoplasms; STAT5 Transcription Factor; Transfection; Tumor Suppressor Proteins | 2009 |
Inhibitory effects of phenolic compounds from needles of Pinus densiflora on nitric oxide and PGE2 production.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Catechin; Cell Line; Dinoprostone; Flavonols; Glucosides; Macrophages; Mice; Nitric Oxide; Phenols; Pinus; Plant Extracts; Quercetin | 2010 |
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by phenolic compounds from roots of Rhododendron mucronulatum.
Topics: Anti-Inflammatory Agents; Antioxidants; Arabinose; Biflavonoids; Catechin; Cell Line; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Glucosides; Humans; Nitric Oxide; Nitric Oxide Synthase Type II; Plant Extracts; Plant Roots; Proanthocyanidins; Quercetin; Rhododendron | 2011 |
Dietary supplementation with high dose of epigallocatechin-3-gallate promotes inflammatory response in mice.
Topics: Animals; Biomarkers; Catechin; Dietary Supplements; Dinoprostone; Inflammation; Interleukin-1beta; Interleukin-6; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Natural Killer T-Cells; Plant Extracts; Spleen; Tea; Tumor Necrosis Factor-alpha | 2012 |
Omega-3 docosahexaenoic acid and procyanidins inhibit cyclo-oxygenase activity and attenuate NF-κB activation through a p105/p50 regulatory mechanism in macrophage inflammation.
Topics: Biflavonoids; Catechin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Docosahexaenoic Acids; Fatty Acids, Omega-3; Humans; I-kappa B Proteins; Inflammation; Interleukin-6; NF-kappa B; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Proanthocyanidins; Transcription Factor RelA | 2012 |
Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.
Topics: Catechin; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Humans; Melanoma; Neoplasm Invasiveness; NF-kappa B; Pyrazoles; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides; Tea; Tetradecanoylphorbol Acetate; Transcription Factor RelA | 2011 |
Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Catechin; Cell Line, Tumor; Dihematoporphyrin Ether; Dinoprostone; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; Inflammation; Mammary Neoplasms, Experimental; Matrix Metalloproteinases, Secreted; Mice; Mice, Inbred C3H; Photochemotherapy; Photosensitizing Agents; Unfolded Protein Response; Vascular Endothelial Growth Factors | 2011 |
Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis.
Topics: Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; Catechin; Cyclooxygenase 2 Inhibitors; Cytokines; Dinoprostone; Disease Models, Animal; Drug Combinations; Extracellular Signal-Regulated MAP Kinases; Intracellular Signaling Peptides and Proteins; Leukotriene B4; Lipoxins; Lipoxygenase Inhibitors; Liver; Lung; Mice, Inbred C57BL; NF-kappa B; Peroxidase; Sepsis | 2012 |
EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts.
Topics: Anthracenes; Benzamides; Catechin; Cell Line; Cells, Cultured; Connective Tissue Growth Factor; Dinoprostone; Dioxoles; Dose-Response Relationship, Drug; Fibroblasts; Flavonoids; Humans; Imidazoles; Lung; MAP Kinase Kinase 4; Mouth Mucosa; Oral Submucous Fibrosis; p38 Mitogen-Activated Protein Kinases; Protease Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2013 |
Effects of flavocoxid, a dual inhibitor of COX and 5-lipoxygenase enzymes, on benign prostatic hyperplasia.
Topics: Animals; Apoptosis; Arachidonate 5-Lipoxygenase; bcl-2-Associated X Protein; Caspase 9; Catechin; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Drug Combinations; Epidermal Growth Factor; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Male; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; RNA, Messenger; Vascular Endothelial Growth Factor A | 2012 |
Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.
Topics: Alprostadil; Antineoplastic Agents, Phytogenic; Blotting, Western; Bridged Bicyclo Compounds; Caproates; Carcinoma, Hepatocellular; Catechin; Cell Movement; Cell Proliferation; Cell Survival; Dinoprostone; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, Gq-G11; Hep G2 Cells; Humans; Immunoassay; Liver Neoplasms; Neoplasm Invasiveness; Receptors, Prostaglandin E, EP1 Subtype; Time Factors | 2012 |
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss | 2012 |
The procyanidin trimer C1 inhibits LPS-induced MAPK and NF-κB signaling through TLR4 in macrophages.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD; Biflavonoids; Catechin; Cell Line; Cyclooxygenase 2; Dinoprostone; Inflammation; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; Mice; NF-kappa B; Nitric Oxide; Proanthocyanidins; Toll-Like Receptor 4 | 2013 |
Prevention of oxidative stress, inflammation and mitochondrial dysfunction in the intestine by different cranberry phenolic fractions.
Topics: Adenosine Triphosphate; Antioxidants; Apoptosis; Biflavonoids; Caco-2 Cells; Catechin; Dinoprostone; Fatty Acids; Humans; Inflammation; Intestines; Lipid Peroxidation; Mitochondria; Oxidative Phosphorylation; Oxidative Stress; Plant Extracts; Proanthocyanidins; Vaccinium macrocarpon | 2015 |
Topical (+)-catechin emulsified gel prevents DMBA/TPA-induced squamous cell carcinoma of the skin by modulating antioxidants and inflammatory biomarkers in BALB/c mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acacia; Administration, Topical; Animals; Antioxidants; Biomarkers; Carcinoma, Squamous Cell; Catechin; Dinoprostone; Drug Evaluation, Preclinical; Emulsions; Humans; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase Type II; Plant Extracts; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2014 |
A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury.
Topics: Animals; Behavior, Animal; Brain Edema; Catechin; Cyclooxygenase Inhibitors; Dinoprostone; Drug Combinations; Hippocampus; Kainic Acid; Leukotriene B4; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Malondialdehyde; MAP Kinase Signaling System; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; Phosphorylation; Protein Processing, Post-Translational; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures; Tumor Necrosis Factor-alpha | 2015 |
Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Body Weight; Catechin; CD3 Complex; Celecoxib; Colitis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Combinations; Eating; Gene Expression Regulation; Hydroxyurea; Leukotriene B4; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Neutrophil Infiltration; Rats; Rats, Sprague-Dawley; Thromboxane B2; Tumor Necrosis Factor-alpha | 2016 |
Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption.
Topics: Administration, Oral; Animals; Anterior Cruciate Ligament; Biflavonoids; Catechin; Cyclooxygenase 2; Diet; Dinoprostone; Disease Models, Animal; Female; Grape Seed Extract; Interleukin-1beta; Male; Mass Spectrometry; Matrix Metalloproteinase 13; Metabolome; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Olea; Osteoarthritis; Phenylethyl Alcohol; Proanthocyanidins; Rabbits; RNA, Messenger; Wounds and Injuries | 2016 |
Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Catechin; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Drug Combinations; Interleukin-1beta; Leukotriene B4; Lipoxygenase Inhibitors; Male; Maze Learning; Memory; Mice, Transgenic; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; tau Proteins | 2017 |
Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma.
Topics: Alprostadil; Apoptosis; Carcinoma, Hepatocellular; Catechin; Cell Movement; Cell Proliferation; Dinoprostone; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Receptors, Prostaglandin E, EP1 Subtype; Wound Healing | 2019 |
Procyanidin A2, a polyphenolic compound, exerts anti-inflammatory and anti-oxidative activity in lipopolysaccharide-stimulated RAW264.7 cells.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Cytokines; Dinoprostone; Heme Oxygenase-1; Inflammation; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Proanthocyanidins; RAW 264.7 Cells; Signal Transduction | 2020 |
Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages.
Topics: Animals; Anti-Inflammatory Agents; Biflavonoids; Catechin; Cathepsin B; Cytokines; Dinoprostone; Gout; Inflammasomes; Inflammation; Interleukin-1beta; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Neutrophils; NLR Family, Pyrin Domain-Containing 3 Protein; Proanthocyanidins; Uric Acid | 2020 |